Recent Quarter Total Invested
$12.89 B
Recent Quarter Institutional Ownership Percentage
93.83%
Total Invested of Last Quarter
$12.82 B
Ownership Percentage of Last Quarter
93.15%
Neurocrine Biosciences, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
BLACKROCK INC. | 08/13/2024 | 14.19 M | $1.95 B | 3.12% | 14.22% |
VANGUARD GROUP INC | 08/13/2024 | 10.06 M | $1.38 B | 1.26% | 10.08% |
STATE STREET CORP | 08/14/2024 | 4.61 M | $634.43 M | 15.50% | 4.62% |
RENAISSANCE TECHNOLOGIES LLC | 08/09/2024 | 2.47 M | $339.79 M | 9.62% | 2.47% |
JPMORGAN CHASE & CO | 08/12/2024 | 2.36 M | $325.28 M | 2.95% | 2.37% |
BELLEVUE GROUP AG | 08/14/2024 | 1.90 M | $261.39 M | -7.65% | 1.90% |
GEODE CAPITAL MANAGEMENT, LLC | 08/09/2024 | 1.82 M | $250.11 M | 6.18% | 1.82% |
PRICE T ROWE ASSOCIATES INC /MD/ | 08/14/2024 | 1.80 M | $247.65 M | -1.21% | 1.80% |
MORGAN STANLEY | 08/14/2024 | 1.54 M | $212.68 M | -25.21% | 1.55% |
DODGE & COX | 08/13/2024 | 1.28 M | $176.33 M | 1.23% | 1.28% |
INVESCO LTD. | 08/13/2024 | 1.26 M | $173.20 M | 10.66% | 1.26% |
AQR CAPITAL MANAGEMENT LLC | 08/14/2024 | 1.22 M | $166.96 M | 22.97% | 1.23% |
GOLDMAN SACHS GROUP INC | 08/13/2024 | 1.13 M | $155.92 M | 46.00% | 1.13% |
DSM CAPITAL PARTNERS LLC | 08/14/2024 | 997,784 | $137.36 M | -12.17% | 1.00% |
BROWN ADVISORY INC | 08/14/2024 | 995,214 | $137.01 M | -8.56% | 1.00% |
ARMISTICE CAPITAL, LLC | 08/14/2024 | 978,488 | $134.71 M | -4.42% | 0.98% |
JANUS HENDERSON GROUP PLC | 08/14/2024 | 971,203 | $133.71 M | -29.55% | 0.97% |
ROCK SPRINGS CAPITAL MANAGEMENT LP | 08/14/2024 | 940,000 | $129.41 M | -10.89% | 0.94% |
BANK OF NEW YORK MELLON CORP | 07/25/2024 | 934,404 | $128.64 M | 1.42% | 0.94% |
UBS ASSET MANAGEMENT AMERICAS INC | 08/14/2024 | 912,064 | $125.56 M | 52.16% | 0.91% |
WELLINGTON MANAGEMENT GROUP LLP | 08/14/2024 | 899,493 | $123.83 M | -10.39% | 0.90% |
PICTET ASSET MANAGEMENT HOLDING SA | 08/13/2024 | 871,324 | $119.96 M | -19.43% | 0.87% |
NORTHERN TRUST CORP | 08/14/2024 | 810,620 | $111.60 M | 13.36% | 0.81% |
FRANKLIN RESOURCES INC | 08/14/2024 | 808,450 | $111.30 M | 1.84% | 0.81% |
BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. | 07/30/2024 | 782,870 | $107.78 M | -0.93% | 0.78% |
BRAIDWELL LP | 08/14/2024 | 759,009 | $104.49 M | 3.94% | 0.76% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/12/2024 | 752,501 | $103.60 M | 3.77% | 0.75% |
CITADEL ADVISORS LLC | 08/14/2024 | 740,939 | $102.01 M | -11.93% | 0.74% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 08/14/2024 | 721,087 | $99.27 M | 1.16% | 0.72% |
ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC | 07/26/2024 | 710,600 | $97.83 M | 40.25% | 0.71% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 08/14/2024 | 691,004 | $95.13 M | 0.00% | 0.69% |
EAGLE ASSET MANAGEMENT INC | 08/12/2024 | 680,034 | $95.28 M | -4.69% | 0.68% |
CAISSE DE DEPOT ET PLACEMENT DU QUEBEC | 08/14/2024 | 656,118 | $90.33 M | 332.56% | 0.66% |
PERCEPTIVE ADVISORS LLC | 08/16/2024 | 649,909 | $89.47 M | -19.21% | 0.65% |
ALLIANCEBERNSTEIN L.P. | 08/14/2024 | 621,865 | $85.61 M | 288.12% | 0.62% |
BANK OF AMERICA CORP /DE/ | 08/14/2024 | 618,931 | $85.21 M | 9.21% | 0.62% |
POLAR CAPITAL HOLDINGS PLC | 08/14/2024 | 610,552 | $84.05 M | -21.28% | 0.61% |
QUBE RESEARCH & TECHNOLOGIES LTD | 08/14/2024 | 601,720 | $82.84 M | 138.94% | 0.60% |
LEGAL & GENERAL GROUP PLC | 08/14/2024 | 574,162 | $79.04 M | 6.31% | 0.58% |
GW&K INVESTMENT MANAGEMENT, LLC | 08/12/2024 | 546,068 | $75.18 M | 3.45% | 0.55% |
1832 ASSET MANAGEMENT L.P. | 08/13/2024 | 541,200 | $74.51 M | 1,370.65% | 0.54% |
FIERA CAPITAL CORP | 08/19/2024 | 527,902 | $72.68 M | 3.20% | 0.53% |
IEQ CAPITAL, LLC | 08/12/2024 | 506,086 | $69.67 M | -0.01% | 0.51% |
JENNISON ASSOCIATES LLC | 08/05/2024 | 499,323 | $68.74 M | 44.54% | 0.50% |
AVIDITY PARTNERS MANAGEMENT LP | 08/14/2024 | 491,000 | $67.60 M | -8.48% | 0.49% |
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM | 08/14/2024 | 485,020 | $66.77 M | -16.46% | 0.49% |
WESTFIELD CAPITAL MANAGEMENT CO LP | 08/14/2024 | 484,777 | $66.74 M | -3.66% | 0.49% |
DIMENSIONAL FUND ADVISORS LP | 08/09/2024 | 472,929 | $65.10 M | 45.51% | 0.47% |
CANDRIAM S.C.A. | 08/05/2024 | 465,467 | $64.08 M | 47.45% | 0.47% |
NORGES BANK | 08/14/2024 | 449,565 | $61.89 M | 100.00% | 0.45% |
Neurocrine Biosciences, Inc.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of NBIX shares?
During the previous two years, 805 institutional investors and hedge funds held shares of Neurocrine Biosciences, Inc.. The most heavily invested institutionals were:
BlackRock Inc.: 14.19 M
VANGUARD GROUP INC: 10.06 M
STATE STREET CORP: 4.61 M
RENAISSANCE TECHNOLOGIES LLC: 2.47 M
JPMORGAN CHASE & CO: 2.36 M
Bellevue Group AG: 1.9 M
-
What percentage of Neurocrine Biosciences, Inc. stock is owned by institutional investors?
93.83% of Neurocrine Biosciences, Inc. stock is owned by institutional investors.
-
How much institutional buying is happening at NBIX ?
Institutional investors have bought a total of 118.43 M shares in the last 24 months. This purchase volume represents approximately $13.69 B in transactions.